BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26988602)

  • 1. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
    van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
    J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
    Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
    J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody-photosensitizer conjugates for targeted photodynamic therapy.
    Heukers R; van Bergen en Henegouwen PM; Oliveira S
    Nanomedicine; 2014 Oct; 10(7):1441-51. PubMed ID: 24394212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
    de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
    Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
    De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
    Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.
    Master A; Malamas A; Solanki R; Clausen DM; Eiseman JL; Sen Gupta A
    Mol Pharm; 2013 May; 10(5):1988-97. PubMed ID: 23531079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
    Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
    Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model.
    van Driel PBAA; Keereweer S; Lowik CWGM; Oliveira S
    Methods Mol Biol; 2022; 2451():521-531. PubMed ID: 35505029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic Breast Cancer Model to Investigate the Therapeutic Efficacy of Nanobody-Targeted Photodynamic Therapy.
    Deken MM; Bhairosingh SS; Vahrmeijer AL; Oliveira S
    Methods Mol Biol; 2022; 2451():547-556. PubMed ID: 35505031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
    Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
    Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.
    Beltrán Hernández I; De Groof TWM; Heukers R; Oliveira S
    Methods Mol Biol; 2022; 2451():505-520. PubMed ID: 35505028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
    Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells.
    Heukers R; Mashayekhi V; Ramirez-Escudero M; de Haard H; Verrips TC; van Bergen En Henegouwen PMP; Oliveira S
    Antibodies (Basel); 2019 Apr; 8(2):. PubMed ID: 31544832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
    Master AM; Livingston M; Oleinick NL; Sen Gupta A
    Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy.
    Mashayekhi V; Xenaki KT; van Bergen En Henegouwen PMP; Oliveira S
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
    Chu PL; Shihabuddeen WA; Low KP; Poon DJJ; Ramaswamy B; Liang ZG; Nei WL; Chua KLM; Thong PSP; Soo KC; Yeo ELL; Chua MLK
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():367-374. PubMed ID: 31299389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
    Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
    Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti-epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin-fold Window Chamber Model.
    Peng W; de Bruijn HS; Ten Hagen TLM; van Dam GM; Roodenburg JLN; Berg K; Witjes MJH; Robinson DJ
    Photochem Photobiol; 2020 May; 96(3):708-717. PubMed ID: 32222965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.